The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. - Wikidata - awgldk - TriplyDB

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.

http://www.wikidata.org/entity/Q31043513

about

Diffusion weighted imaging in gynecological malignancies - present and future A Pilot Study of Quantitative MRI Parametric Response Mapping of Bone Marrow Fat for Treatment Assessment in Myelofibrosis.Neoplasia: Where We Have Been and Where We Are Going Characterizing tumor response to chemotherapy at various length scales using temporal diffusion spectroscopy DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma Neoplasia: the second decade.Diffusion-weighted MRI as a biomarker for treatment response in glioma Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients Image registration for quantitative parametric response mapping of cancer treatment response Between-Scanner and Between-Visit Variation in Normal White Matter Apparent Diffusion Coefficient Values in the Setting of a Multi-Center Clinical Trial.Free-breathing 3D diffusion MRI for high-resolution hepatic metastasis characterization in small animals.Clinical applications of diffusion-weighted magnetic resonance imaging in diagnosis of renal lesions - a systematic review.Early Detection of Treatment-Induced Mitotic Arrest Using Temporal Diffusion Magnetic Resonance Spectroscopy.A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone Water spin dynamics during apoptotic cell death in glioma gene therapy probed by T1rho and T2rho.Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy.MRI for identification of progression in brain tumors: from morphology to function.Determining glioma response to radiation therapy using recombinant peptides.Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy.Advances in MRI assessment of gliomas and response to anti-VEGF therapy.Imaging tumor hypoxia by magnetic resonance methods.Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity.Predicting and monitoring cancer treatment response with diffusion-weighted MRI.Prediction of glioblastoma multiform response to bevacizumab treatment using multi-parametric MRI.Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri.Assessment of multiexponential diffusion features as MRI cancer therapy response metrics Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study Development and applications of photo-triggered theranostic agents Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas.Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.

P2860

Q26749354-119A89E3-004F-4655-B294-4DC9CA6E904A Q27342179-72A334D6-AEAB-4D18-83F0-16322DAE0A25 Q28395095-5711A265-FDCB-477D-BF44-05554C640078 Q28728870-ACF24664-3976-4C69-85CC-FB0F712F6162 Q28730443-1107CD6F-ECC3-43B6-AAA8-AAAEC1ED6191 Q28743461-3862426D-0209-431B-AD12-3F2318E2FBDF Q30484000-0121D25D-0EB1-4231-B2AC-B092CFEA694C Q30660991-5AC74FEA-2A8A-48FA-B391-5371DE5FFC58 Q30692995-680381E6-451E-409E-B486-4E5F13887D61 Q30810432-AB39ABCC-4BB0-49A8-BC58-C067EAD58217 Q30912628-A97CA72E-18ED-4ED7-93A4-5D929C06C13D Q31018721-1CEF8ECE-9BC7-4C56-90CD-064A537DE738 Q31030957-32B1DC80-55D5-404D-9AF9-BD0862B8EF68 Q31107517-3F6D820A-A4CD-44D7-8574-D708D72E2D8C Q31140219-6294518C-A4E1-46C2-BCF1-C88ECCC2BD50 Q31156729-68655664-2BFE-405B-9D39-318AD1E01F2A Q33372678-FF348737-366D-4713-8E18-2A0B96CF63A4 Q33377547-030ADB74-0B86-4BA2-9FFF-FB5B52013050 Q33382467-587A71C3-A0DD-4BA1-A553-98B2A689A459 Q33388183-616376E6-5787-4EDF-B374-2EFD16B44448 Q33496147-305C1C71-A73C-4436-A6CA-2720EAC28447 Q33793253-998D04FF-90E4-490B-AA24-AD5B8A9CD053 Q33801254-E20FF305-910E-4C90-98A5-701B6BCDA9EF Q33888366-8E51E8D7-81B0-448A-9C7B-62F682C922C2 Q33989536-57912BB6-A273-4745-ABEF-58EA17B199B7 Q34052992-3E5E8FFA-FCE7-4BF7-B3A8-094C6A2F3C9C Q34130827-2850ED2A-90D7-467B-BA52-1A381432F1C3 Q34206891-F122D0E0-706A-4EA0-896E-48DFE0567A88 Q34249651-65AEDDE6-C53E-455A-B61E-3493A7181C09 Q34302644-774FE59F-2735-4592-B1BE-8BBC95C95270 Q34349286-175BA73A-394D-46AC-8D1E-90744BB75CB8 Q34553361-04A218E3-1306-4E1C-AB48-5DD022993E2A Q35028897-E1F62711-200A-4C98-A6FC-C0869D9C906B Q35224703-AC4D577D-A4AE-4E25-A2C4-12DF60148781 Q35225259-A4FAE173-A329-4C2F-B0C7-C85A62389786 Q35598954-74F47F71-EFA7-4D0F-A6DB-749290DEECD7 Q35600833-6A07881E-FF57-4F40-A2C4-A087736581D1 Q35698555-656BF188-ABBC-4453-AD69-3A2C1649659C Q35760662-4B85B6BC-CE8E-40A3-998C-4D63357EF6CB Q35771783-674FD796-9965-40CB-838F-8B17CC4D57FB

P2860

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.

http://www.wikidata.org/entity/Q31043513

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

The functional diffusion map: ...... n of cancer treatment outcome.

@ast

The functional diffusion map: ...... n of cancer treatment outcome.

@en

type

label

The functional diffusion map: ...... n of cancer treatment outcome.

@ast

The functional diffusion map: ...... n of cancer treatment outcome.

@en

prefLabel

The functional diffusion map: ...... n of cancer treatment outcome.

@ast

The functional diffusion map: ...... n of cancer treatment outcome.

@en

P1433

Q31043513-2176B95C-BE16-41CC-B806-CECA45B313AE

P1476

Q31043513-73C6A793-FD72-499F-937A-A219EA14F7CB

P2093

Q31043513-74031A9F-D8F4-49F0-801C-6FF3C0816895

Q31043513-745100A0-486F-4428-90CF-BE6FC435AF01

Q31043513-82AD8A91-A260-4F2A-AA5A-91A3877BCD90

Q31043513-8A95944B-7CAB-4A3B-9FE0-687E4953EDE9

Q31043513-923398D8-F3D0-48D9-A809-99C2732414CD

Q31043513-9A309076-2BBC-49FE-8A14-6A9CEFF56A02

Q31043513-A5DDFE0E-9067-440A-8DFE-8721877BD0E1

Q31043513-BFA10139-A089-4276-ADBF-101CF4BF6C01

P2860

Q31043513-02A7F08D-1FA3-4BD5-9BDD-CC8A09382279

Q31043513-07391A79-EFC2-467A-81E9-618298026181

Q31043513-13A8D47D-988B-44AB-A69B-25377A0E8FCC

Q31043513-23C8EA13-BF40-488E-9772-BEC138CCCA08

Q31043513-3488C0A5-BE1E-4C8C-9E1E-C7D8FACA4A1A

Q31043513-398F4F04-0D2A-4E82-B8F8-8E58EB6D73EA

Q31043513-3ABBA562-58D9-4F3D-8281-B12A6036B68D

Q31043513-3DADDBF6-0B33-41DF-BE4D-1AA5A3451A91

Q31043513-3F42EF41-D4EF-44E7-B557-AB36C6A0D3A3

Q31043513-40D1865E-C6B5-484E-BC9F-4C07FA2F9B5E

P304

Q31043513-F87778F7-19EE-47F7-8DC9-B9EBC126E6A5

P31

Q31043513-74B84BF7-756A-4019-A815-93EEFA06D952

P356

Q31043513-58702DE9-5576-4A3F-8462-749F8B1CF978

P433

Q31043513-11384891-67D6-4E8D-A57E-C7D41E1BADDB

P478

Q31043513-142A26FD-4987-4E9D-A1F2-6482546A33FE

P50

Q31043513-ED71EA8A-C006-4FEE-BE4B-82531A9E84A5

P577

Q31043513-A097E7AA-1450-4AAC-AB1C-16F335FCF4EF

P5875

Q31043513-9A764214-4001-4F2A-92F9-FA3322F8403C

P698

Q31043513-83DC681E-3C67-4CD8-81E6-22BA640E2A44

P921

Q31043513-7F0ABDF5-33A7-41C4-AC74-30CF4F43E8AE

P932

Q31043513-64EDC983-A96B-4420-A340-50E2758B7259

P356

P1433

P1476

The functional diffusion map: ...... n of cancer treatment outcome.

@en

P2093

Alnawaz Rehemtulla

http://www.w3.org/2001/XMLSchema#string

Benjamin A Hoff

http://www.w3.org/2001/XMLSchema#string

Bradford A Moffat

http://www.w3.org/2001/XMLSchema#string

Brian D Ross

http://www.w3.org/2001/XMLSchema#string

Charles R Meyer

http://www.w3.org/2001/XMLSchema#string

Daniel E Hall

http://www.w3.org/2001/XMLSchema#string

Paul E McKeever

http://www.w3.org/2001/XMLSchema#string

Timothy D Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.

Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.

Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study.

Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging.

Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.

Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI

P304

259-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.05844

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Thomas L Chenevert

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7025773

http://www.w3.org/2001/XMLSchema#string

P698

16756718

http://www.w3.org/2001/XMLSchema#string

P921

P932

1600674

http://www.w3.org/2001/XMLSchema#string